Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis

BACKGROUND: Most patients with moderate and severe chronic obstructive pulmonary disease (COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however, unclear if and what drug treatments should be added to LABAs to reduce exacerbations, which is an important goal of COPD man...

Descripción completa

Detalles Bibliográficos
Autores principales: Mills, Edward J, Druyts, Eric, Ghement, Isabella, Puhan, Milo A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072154/
https://www.ncbi.nlm.nih.gov/pubmed/21487451
http://dx.doi.org/10.2147/CLEP.S16235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072154/
https://www.ncbi.nlm.nih.gov/pubmed/21487451
http://dx.doi.org/10.2147/CLEP.S16235

Ejemplares similares